Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction

To assess whether beta-blocker use is associated with cardiovascular events and mortality in patients with heart failure with preserved ejection fraction (HFpEF), this study analyzed the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial data using Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujimoto, Tetsuro, Kajio, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015007/
https://www.ncbi.nlm.nih.gov/pubmed/29934526
http://dx.doi.org/10.1038/s41598-018-27799-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015007/
https://www.ncbi.nlm.nih.gov/pubmed/29934526
http://dx.doi.org/10.1038/s41598-018-27799-y

Ejemplares similares